智通财经APP讯，同仁堂国药(03613)发布公告，公司与中免国际有限公司(中免国际)签署了战略合作协议(战略合作协议)。
公司与中免国际视彼此为重要合作伙伴，将充分发挥各自领域的优势，通过战略合作协议涉及的合作实现共同发展、利益最大化。双方建立合作机制，实现资源整合，促进互利共赢。双方努力创造条件，将最具竞争力的优势资源投入合作当中，共同致力于拓展公司的海外市场，重点拓展“一带一路”沿线国家及东南亚地区。
战略合作协议的签订，为双方正式合作奠定基础，若双方顺利达成正式合作，将有利于充分发挥各自领域优势，利用双方优势资源的共享、协同、集成与互补，以中医药文化助力国潮消费品全球传播，共同致力于在以国内大循环为主体、国内国际双循环相互促进的新发展格局下，进一步聚焦中医药价值，为全球民众提供多元化的健康解决方案，共谋大健康产业未来。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.